Usefulness of the Serial Measurement of Vi Antibodies
- PMID: 29351593
- PMCID: PMC6005017
- DOI: 10.1093/cid/cix1151
Usefulness of the Serial Measurement of Vi Antibodies
Comment on
-
Seroefficacy of Vi Polysaccharide-Tetanus Toxoid Typhoid Conjugate Vaccine (Typbar TCV).Clin Infect Dis. 2018 Jun 18;67(1):18-24. doi: 10.1093/cid/cix1145. Clin Infect Dis. 2018. PMID: 29351594 Clinical Trial.
References
-
- Voysey M, Pollard AJ. Sero-efficacy of Vi-polysaccharide tetanus-toxoid typhoid conjugate vaccine (Typbar-TCV). Clin Infect Dis 2018; 67: 18–24. - PubMed
-
- Mohan VK, Varanasi V, Singh A, et al. . Safety and immunogenicity of a Vi polysaccharide-tetanus toxoid conjugate vaccine (Typbar-TCV) in healthy infants, children, and adults in typhoid endemic areas: a multicenter, 2-cohort, open-label, double-blind, randomized controlled phase 3 study. Clin Infect Dis 2015; 61: 393–402. - PubMed
-
- Keddy KH, Klugman KP, Hansford CF, Blondeau C, Bouveret le Cam NN. Persistence of antibodies to the Salmonella typhi Vi capsular polysaccharide vaccine in South African school children ten years after immunization. Vaccine 1999; 17:110–3. - PubMed
-
- Anwar E, Goldberg E, Fraser A, Acosta CJ, Paul M, Leibovici L. Vaccines forpreventing typhoid fever. Cochrane Database Syst Rev 2014; 1:CD001261. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources